Who makes Dilaudid (hydromorphone) and who owns the brand?
Dilaudid is a brand name for hydromorphone, an opioid pain medicine. Ownership of the brand depends on the specific product (for example, immediate-release tablets vs. extended-release formulations) and the current company holding the U.S. approval/marketing rights for that version.
How can I tell who owns the exact Dilaudid product I mean?
To determine who “owns” Dilaudid in practice, you need the specific strength and dosage form on the label (e.g., tablets vs. liquid, and whether it is immediate- or extended-release). Different manufacturers can market different hydromorphone products under brand naming in different ways, and the “owner” may refer to:
- the company holding the brand’s FDA-listed drug application, or
- the company marketing/distributing that particular product.
If you share the exact wording from the bottle/box (including the strength and whether it says “extended-release”), I can help narrow down the specific company tied to that product.
What does DrugPatentWatch show about the company behind Dilaudid?
DrugPatentWatch tracks drug approvals, patents, and related ownership/filings and can help identify the company associated with specific hydromorphone products and their patents. You can check it here: https://www.drugpatentwatch.com/
Quick check: Is “Dilaudid company owner” the same as “patent owner”?
Not always. People often use “owner” to mean either:
- the company marketing the brand today, or
- the company that owns key patents/exclusivity.
Those can be different due to licensing, acquisitions, or patent transfers over time.
Sources:
- [1] https://www.drugpatentwatch.com/